Sahil Sheth is an associate in the Antitrust Department. Sahil counsels leading corporations and private equity sponsors on complex antitrust matters, with an emphasis on merger clearance and investigations by the U.S. Department of Justice, U.S. Federal Trade Commission, state attorneys general and international enforcers. Sahil counsels clients throughout the transaction lifecycle on antitrust risk, regulatory strategy and compliance, and has substantial experience managing agency reviews and high-stakes investigations. Sahil’s experience spans a broad range of industries, including pharmaceuticals, healthcare, telecommunications, energy, and consumer products.
Sahil’s notable representations include:
- Metsera, a New York-based clinical-stage biopharmaceutical company, in its sale to Pfizer for $10 billion. The matter won Global Competition Review’s 2026 Antitrust Matter of the Year
- Alkermes, an Ireland-based neuroscience-focused biopharmaceutical company, in its $2.37 billion acquisition of Avadel Pharmaceuticals, an Ireland-based pharmaceutical company
- Crinetics Pharmaceuticals in its $10 billion acquisition by Vertex Pharmaceuticals
- Verve Therapeutics, a clinical-stage gene-editing company targeting cardiovascular disease, in its $1.3 billion acquisition by Eli Lilly
- Galapagos in a research and development collaboration with Gilead in connection with Gilead’s $1.675 billion acquisition of Ouro Medicine
- GSK in connection with:
- in its $950 million acquisition of 35Pharma
- up-to-$690 million exclusive licensing agreement with Alfasigma S.p.A.
- Inhibrx in the $2.2 billion sale of INBRX-101 to Sanofi and the related spin-off of Inhibrx’s non-INBRX-101 business
- IonQ in its $1.8 billion acquisition of SkyWater Technology
- Oak Hill Capital Partners in numerous transactions including:
- its investment in IMA Financial Group, alongside New Mountain Capital, as part of an equity recapitalization transaction that values IMA at $4 billion
- GoNetspeed and Greenlight Networks, portfolio companies of Oak Hill Capital, in their combination and approximately $2 billion sale to a 50/50 strategic fiber joint venture formed by Oak Hill and T-Mobile
- its acquisition of Hunter Communications
- its investment in Race Communications
- General Atlantic in connection with:
- its strategic investment in Boats Group, alongside Canada Pension Plan Investment Board
- an investor consortium backing a new AI-native enterprise services firm formed by Anthropic, Blackstone, Hellman & Friedman and Goldman Sachs
- TPG Capital in its investment in G&A Partners
- Long Range Capital in its acquisition of 24 Hour Fitness
- Five Arrows in its acquisition of Springbrook Software, and investment in Blue Mountain
- Golden Gate Capital in its sale of Vercara to Digicert
- Equitable in its $22 billion merger of equals with Corebridge Financial
- Qualcomm in connection with:
- its acquisition of Alphawave Semi, a UK-based high-speed wired connectivity and compute technologies company, with an enterprise value of approximately $2.4 billion
- its acquisition of Autotalks, the leading manufacturer of semiconductors used in next-generation safety technology for vehicles
- Polaris in the separation of Indian Motorcycle and subsequent sale of a majority stake in the new company to Carolwood LP
- Roark Capital Group in connection with its successful acquisition of Subway Restaurants, one of the world’s largest quick service restaurant brands
- Endeavor Energy Resources in its $26 billion merger with Diamondback Energy, a Texas-based independent oil and natural gas company
- Metronet, the country’s largest and fastest-growing privately owned fiber-to-the-home company, and shareholder Oak Hill Capital on Metronet’s acquisition by a new joint venture between KKR and T-Mobile
- IBM in its $6.4 billion acquisition of HashiCorp, a leading hybrid cloud automation vendor
- Red Hat in its acquisition of Neural Magic, a pioneer in software and algorithms that accelerate generative AI inference workloads
- Secureworks in its $859 million acquisition by Sophos
- Envestnet in its $4.5 billion take-private deal with Bain Capital
- DeepIntent in its sale to Vitruvian Partners
- Rite Aid in connection with its chapter 11 bankruptcy proceedings and CVS’s acquisition of certain Rite Aid assets. The transaction included CVS’s purchase of the prescription files of 625 Rite Aid pharmacies located in 15 states within CVS’s service areas, as well as CVS’s acquisition and continued operation of 64 Rite Aid stores in Idaho, Oregon, and Washington
- 23andMe’s $305 million bankruptcy sale to TTAM Research Institute
- Tricon Residential in its $3.5 billion take-private sale to Blackstone Real Estate Partners X and Blackstone Real Estate Income Trust
- ZT Systems in its $4.9 billion acquisition by Advanced Micro Devices
- RXO's $1.02 billion acquisition of Coyote Logistics
- Atrium Health's $75 million acquisition of Harbin Clinic
- QXO's $11 billion acquisition of Beacon Roofing Supply
- ForgeRock, a global digital identity leader, in its acquisition by Thoma Bravo, a leading technology private equity firm, with portfolio company Ping that competes against ForgeRock, a transaction valued at approximately $2.3 billion*
*Matter worked on prior to joining Paul, Weiss
